These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2041620)

  • 1. [Ciprofloxacin: a new fluoroquinolone for the treatment of respiratory tract infections].
    Scarlini GF; Germani M; Martino M; Perna R
    Minerva Med; 1991 May; 82(5):293-9. PubMed ID: 2041620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ciprofloxacin in the treatment of urinary and respiratory tract infections in patients with chronic liver disease.
    Galante D; Esposito S; Barba D; Giusti G
    Chemioterapia; 1986 Oct; 5(5):322-6. PubMed ID: 3791479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ciprofloxacin in the treatment of respiratory infections].
    Poggi F; Tognazzi F; Doddi M; Lauri A; Placidi C
    Clin Ter; 1990 Jul; 134(2):111-7. PubMed ID: 2147611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The efficacy and tolerance of Bay-o-9867 (ciprofloxacin) in the treatment of infections of the urinary tract and of the lower respiratory tract].
    Quartieri F; Bolognesi S; Sconosciuto F
    Recenti Prog Med; 1994 Feb; 85(2):96-100. PubMed ID: 8184195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ciprofloxacin by the intravenous route in the treatment of respiratory infections].
    Mangiarotti P; Manara G; Bianchi L; Piccioni PD; Grassi C
    G Ital Chemioter; 1989; 36(1-3):89-94. PubMed ID: 2488917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy of ciprofloxacin in the treatment of patients with respiratory tract infections in Japan.
    Kobayashi H
    Am J Med; 1987 Apr; 82(4A):169-73. PubMed ID: 3555031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ciprofloxacin in the treatment of bronchopulmonary infections].
    Girbino G; Giacobbe G; Quattrone G; Fiorello G
    Riv Eur Sci Med Farmacol; 1990; 12(4-5):259-63. PubMed ID: 2103966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Results of ciprofloxacin therapy in urinary and respiratory tract infections].
    Polubiec A; Jórasz I; Kłos K; Ozarek-Medyńska T; Pietrzak J; Starzyńska R; Stepka K
    Pol Tyg Lek; 1990 Jan 22-29; 45(4-5):85-9. PubMed ID: 2395758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of oral erythromycin ethylsuccinate and ciprofloxacin in the treatment of acute respiratory tract infections.
    Feld MS; Carnegie C; Macklin J; Coles S
    Br J Clin Pract; 1990 Oct; 44(10):404-8. PubMed ID: 2268518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of intravenous ciprofloxacin in patients with nosocomial lower respiratory tract infections. Impact of plasma concentrations, organism, minimum inhibitory concentration, and clinical condition on bacterial eradication.
    Peloquin CA; Cumbo TJ; Nix DE; Sands MF; Schentag JJ
    Arch Intern Med; 1989 Oct; 149(10):2269-73. PubMed ID: 2508586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ciprofloxacin in severe infections.
    Aswapokee N; Pruksachatvuthi S; Aswapokee P
    J Med Assoc Thai; 1990 Jun; 73(6):315-20. PubMed ID: 2230626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical experience with ciprofloxacin: analysis of a multicenter study.
    Karimi K
    Indiana Med; 1990 Apr; 83(4):266-9. PubMed ID: 2185309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ciprofloxacin: an update on clinical experience.
    Arcieri G; Griffith E; Gruenwaldt G; Heyd A; O'Brien B; Becker N; August R
    Am J Med; 1987 Apr; 82(4A):381-6. PubMed ID: 3555063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of Streptococcus pneumoniae infection treatment failures associated with fluoroquinolone resistance.
    Fuller JD; Low DE
    Clin Infect Dis; 2005 Jul; 41(1):118-21. PubMed ID: 15937772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ciprofloxacin in the treatment of respiratory infections. Analysis of an Italian series].
    Maggiolo F; Bianchi W; Ohnmeiss H
    G Ital Chemioter; 1988; 35(1-3):39-44. PubMed ID: 3256511
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy and safety of oral ciprofloxacin in the treatment of respiratory tract infections associated with chronic hepatitis.
    Esposito S; Galante D; Bianchi W; Gagliardi R
    Am J Med; 1987 Apr; 82(4A):211-4. PubMed ID: 3555038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ciprofloxacin: an oral quinolone for the treatment of infections with gram-negative pathogens. Committee on Antimicrobial Agents. Canadian Infectious Disease Society.
    Louie TJ
    CMAJ; 1994 Mar; 150(5):669-76. PubMed ID: 8313286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pefloxacin in the treatment of lower respiratory tract infections].
    Dericoloso A; Tranchese D; Bianco A; Cuccurullo S; Moro RA; Micillo E
    Arch Monaldi Mal Torace; 1990; 45(1):21-9. PubMed ID: 1669257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled, comparative study of ciprofloxacin versus ampicillin in treatment of bacterial respiratory tract infections.
    Wollschlager CM; Raoof S; Khan FA; Guarneri JJ; LaBombardi V; Afzal Q
    Am J Med; 1987 Apr; 82(4A):164-8. PubMed ID: 3555030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The treatment of gastrointestinal infections with ciprofloxacin].
    Ippolito A; La Gioia G; Matarrese M; Resta F; Angelini P; Ruffo F
    Minerva Med; 1991 Apr; 82(4):181-7. PubMed ID: 2017314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.